Market Share of Anthrax Treatment Industry
The anthrax treatment market is fragmented due to the availability of more treatment options from various market players. There are a considerable number of companies developing therapeutics that are quite intense. Factors such as the increase in the development of new therapies and an increase in research funding will provide considerable growth opportunities for anthrax treatment manufacturers. The major players include Nighthawk Biosciences, Inc. (Elusys Therapeutics, Inc.), Almirall, LLC, Emergent, Paratek Pharmaceuticals, Inc., GSK plc, Teva Pharmaceuticals Industries Ltd., Bayer AG, Pfizer Inc., and Lilly.
Anthrax Treatment Market Leaders
-
Pfizer Inc.
-
Emergent
-
Nighthawk Biosciences, Inc. (Elusys Therapeutics Inc.)
-
Almirall, LLC
-
Paratek Pharmaceuticals, Inc.
*Disclaimer: Major Players sorted in no particular order